Human Augmentation in Healthcare Market Outlook and Forecasts 2022 – 2030
Bionics represents the application of biological methods and systems found in nature, leverage to support the healthcare industry via electrically and/or mechanically powered artificial devices. Devices include artificial organs, body parts, and exoskeleton, which either replaces damaged or weakened body parts. These devices act as the original functions very closely. The exoskeleton suit has also been used in other purposes like rehabilitation and elder care.
Despite the availability of some prototype bionic devices, and applications within the military, the greatest market potential lies within medical implant innovation. This research addresses the current markets of bionics for healthcare including product range, potential application areas, industry impact, and market competition. The report also analyzes the growth factors of the bionics market and leading vendor companies.
Companies in Report:
Abbott Laboratories
AbbVie Inc.
Abiomed
Asahi Kasei Kuraray Medical Co. Ltd.
Baxter International
Bionic Power
Boston Scientific Corporation
Cloud Bionics
Cochlear Ltd.
Conclusions and Market Outlook
Edwards Lifesciences Corporation
Ekso Bionics Holdings Inc.
ExoAtlet
Human Assistance
LivaNova PLC
Lockheed Martin Corporation
Medtronic plc
Orthofix Holdings Inc.
Ossur Corporate
Otto Bock HealthCare GmBH
RB3D
Real Life Bionic Humans
Sarcos Corporation
Sonova Holding AG
Spring Active
SRI International
SynCardia Systems LLC
Zimmer Biomet Holdings
- 1.0 Executive Summary
- 2.0 Introduction
- 1.1 Bionics Overview
- 1.2 Bionics Products and Application Industry
- 1.3 Bionics Growth Drivers
- 1.3.1 Healthcare Technology Advancement
- 1.3.2 Aging Population to Increase Organ Failure
- 1.3.3 Accident to Amputations
- 1.3.4 Exoskeleton Application
- 1.3.5 Substitute of Robotics
- 1.3.6 Government R&D Initiative
- 1.3.7 Increase of Income Especially in Emerging Economies
- 1.4 Bionics Market Limitations
- 1.4.1 High Cost of Device and Treatment
- 1.4.2 Government Regulations and Strict Approval process
- 1.4.3 Lack of Surgical Expertise
- 1.5 Bionics Impact on Society
- 1.5.1 Positive Impact
- 1.5.2 Negative Impact
- 2 Bionics Technology and Market Development
- 2.1 Medical Bionics Products
- 2.2 Orthotics and Prosthetics
- 2.3 Artificial Organ
- 2.4 Powered Exoskeleton
- 2.4.1 Medical Exoskeleton
- 2.4.2 Military Exoskeleton
- 2.4.3 Assistive Exoskeleton
- 2.5 Human Bionics
- 2.6 Mechanical vs. Electronics Bionics
- 2.7 Artificial Implants vs. Wearable Bionics
- 2.8 3D Printing and Bionics
- 2.9 Bionics and Artificial Intelligence
- 2.10 Nanotechnology and Bionics
- 2.11 Business Biomimetic
- 2.12 Cybernetic Organism
- 2.13 Bionics Industry Landscape
- 3 Use Cases and Examples
- 3.1 HELLEN – The Exoskeleton
- 3.2 The ‘Fit-Bit’ for Tracking and Predicting Epilepsy Seizures
- 3.3 Designing an Exoskeleton for Fitness
- 3.4 Robotic Exoskeleton Case Study
- 3.5 ReWalk Exoskeleton
- 3.6 Magnetic Encoders Allows the Building of ‘Life-Changing’ Exoskeletons
- 3.7 Indego Exoskeleton
- 4 Human Augmentation Market Analysis and Revenue Forecasts
- 4.1 Combined Bionics Revenue 2022 – 2030
- 4.2 Bionics Revenue by Industry Vertical 2022 – 2030
- 4.3 Medical Bionics Revenue 2022 – 2030
- 4.3.1 Medical Bionics Revenue by Product Category
- 4.3.2 Medical Bionics Revenue by Application Type
- 4.3.3 Implantable Medical Bionics Revenue by Product Type
- 4.3.4 Medical Bionics Revenue by Technology Type
- 4.3.5 Medical Mechanical Bionics Revenue by Product Type
- 4.3.6 Medical Bionics Revenue by End User Type
- 4.3.7 Medical Bionics Revenue by Region
- 4.3.8 North America Medical Bionics Revenue by Country
- 4.3.9 Europe Medical Bionics Revenue by Country
- 4.3.10 APAC Medical Bionics Revenue by Country
- 4.3.11 LAMEA Medical Bionics Revenue by Country
- 4.4 Defense Exoskeleton Bionics Revenue 2022 – 2030
- 4.4.1 Defense Exoskeleton Bionics Revenue by Product Category
- 4.4.2 Defense Exoskeleton Bionics Revenue by Technology Type
- 4.4.3 Defense Exoskeleton Bionics Revenue by Region
- 4.4.4 North America Defense Exoskeleton Bionics Revenue by Country
- 4.4.5 APAC Defense Exoskeleton Bionics Revenue by Country
- 4.4.6 Europe Defense Exoskeleton Bionics Revenue by Country
- 4.4.7 ROW Defense Exoskeleton Bionics Revenue by Country
- 5 Company and Analysis
- 5.1 Strategic Initiatives
- 5.2 Abbott Laboratories
- 5.3 AbbVie Inc.
- 5.4 Abiomed
- 5.5 Asahi Kasei Kuraray Medical Co. Ltd.
- 5.6 Baxter International
- 5.7 Zimmer Biomet Holdings
- 5.8 Boston Scientific Corporation
- 5.9 Cochlear Ltd.
- 5.10 Edwards Lifesciences Corporation
- 5.11 Ekso Bionics Holdings Inc.
- 5.12 LivaNova PLC
- 5.13 Medtronic plc
- 5.14 Orthofix Holdings Inc.
- 5.15 Otto Bock HealthCare GmBH
- 5.16 Sonova Holding AG
- 5.17 Ossur Corporate
- 5.18 SynCardia Systems LLC
- 5.19 Bionic Power
- 5.20 ExoAtlet
- 5.21 Lockheed Martin Corporation
- 5.22 RB3D
- 5.23 Sarcos Corporation
- 5.24 Spring Active
- 5.25 SRI International
- 6 Conclusions and Market Outlook
- 6.1 Real Life Bionic Humans
- 6.2 Human Assistance
- 6.3 Cloud Bionics
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook